1 | David MC, Randal SW and Stephen YL: Head and neck cancer. Cancer. 113 (Suppl 7):S1911?S1932. 2008. View Article : Google Scholar |
2 | Laraway DC, Lakshmiah R, Lowe D, Roe B and Rogers SN: Quality of life in older people with oral cancer. Br J Oral Maxillofac Surg. 50:715?720. 2012. View Article : Google Scholar : PubMed/NCBI |
3 | Sudbø J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 345:376?377. 2001. View Article : Google Scholar |
4 | Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM and Tsai CC: Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 24:450?453. 1995. View Article : Google Scholar : PubMed/NCBI |
5 | Bernier J and Cooper JS: Chemoradition after surgery for high-risk head and neck cancer patients: How strong is the evidence? Oncologist. 10:215?224. 2005. View Article : Google Scholar : PubMed/NCBI |
6 | Chen CJ, You SL, Lin LH, Hsu WL and Yang YW: Cancer epidemiology and control in Taiwan: A brief review. Jpn J Clin Oncol. 32 (Suppl):S66?S81. 2002. View Article : Google Scholar : PubMed/NCBI |
7 | Mandal BK and Suzuki KT: Arsenic round the world: A review. Talanta. 58:201?235. 2002. View Article : Google Scholar : PubMed/NCBI |
8 | Calatayud M, Devesa V and V?lez D: Differential toxicity and gene expression in Caco-2 cells exposed to arsenic species. Toxicol Lett. 218:70?80. 2013. View Article : Google Scholar : PubMed/NCBI |
9 | Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al: Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:3354?3360. 1997. View Article : Google Scholar : PubMed/NCBI |
10 | Yedjou C, Tchounwou P, Jenkins J and McMurray R: Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol. 3:282010. View Article : Google Scholar : PubMed/NCBI |
11 | Liu Q, Hilsenbeck S and Gazitt Y: Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood. 101:4078?4087. 2003. View Article : Google Scholar : PubMed/NCBI |
12 | Mandegary A, Torshabi M, Seyedabadi M, Amirheidari B, Sharif E and Ghahremani MH: Indomethacin-enhanced anticancer effect of arsenic trioxide in A549 cell line: Involvement of apoptosis and phospho-ERK and p38 MAPK pathways. Biomed Res Int. 2013:2375432013. View Article : Google Scholar : PubMed/NCBI |
13 | Wang HY, Zhang B, Zhou JN, Wang DX, Xu YC, Zeng Q, Jia YL, Xi JF, Nan X, He LJ, et al: Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex. Cell Death Dis. 10:4532019. View Article : Google Scholar : PubMed/NCBI |
14 | Kim EY, Lee SS, Shin JH, Kim SH, Shin DH and Baek SY: Anticancer effect of arsenic trioxide on cholangiocarcinoma: In vitro experiments and in vivo xenograft mouse model. Clin Exp Med. 14:215?224. 2014. View Article : Google Scholar : PubMed/NCBI |
15 | Mu YF, Chen YH, Chang MM, Chen YC and Huang BM: Arsenic compounds induce apoptosis through caspase pathway activation in MA-10 Leydig tumor cells. Oncol Lett. 18:944?954. 2019.PubMed/NCBI |
16 | Byun JM, Lee DS, Landen CN, Kim DH, Kim YN, Lee KB, Sung MS, Park SG and Jeong DH: Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells. Acta Oncol. 58:1594?1602. 2019. View Article : Google Scholar : PubMed/NCBI |
17 | Kim MJ, Jung JH, Lee WS, Yun JW, Lu JN, Yi SM, Kim HJ, Chang SH, Kim GS, Hong SC and Ha WS: Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells. Oncol Rep. 31:2305?2311. 2014. View Article : Google Scholar : PubMed/NCBI |
18 | Nagappan A, Lee WS, Yun JW, Lu JN, Chang SH, Jeong JH, Kim GS, Jung JM and Hong SC: Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells. PLoS One. 12:e01745912017. View Article : Google Scholar : PubMed/NCBI |
19 | Mann KK, Wallner B, Lossos IS and Miller WH Jr: Darinaparsin: A novel organic arsenical with promising anticancer activity. Expert Opin Investig Drugs. 18:1727?1734. 2009. View Article : Google Scholar : PubMed/NCBI |
20 | Cheng X, Quint?s-Cardama A, Golemovic M, Zingaro R, Gao MZ, Freireich EJ, Andreeff M, Kantarjian HM and Verstovsek S: The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells. Anticancer Res. 32:2871?2880. 2012.PubMed/NCBI |
21 | Kasibhatla S and Tseng B: Why target apoptosis in cancer treatment? Mol Cancer Ther. 2:573?580. 2003.PubMed/NCBI |
22 | D'Arcy MS: Cell death: A review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 43:582?592. 2019. View Article : Google Scholar : PubMed/NCBI |
23 | Ashkenazi A and Dixit VM: Death receptors: Signaling and modulation. Science. 281:1305?1308. 1998. View Article : Google Scholar : PubMed/NCBI |
24 | Akao Y, Nakagawa Y and Akiyama K: Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455:59?62. 1999. View Article : Google Scholar : PubMed/NCBI |
25 | Chen GQ, Zhu J, Shi XG, Ni JN, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, et al: In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR/PML proteins. Blood. 88:1052?1061. 1996. View Article : Google Scholar : PubMed/NCBI |
26 | You Z, Liu SP, Du J, Wu YH and Zhang SZ: Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review. J Oral Pathol Med. 48:201?205. 2019. View Article : Google Scholar : PubMed/NCBI |
27 | Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 23:2838?2849. 2004. View Article : Google Scholar : PubMed/NCBI |
28 | Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D and Murata Y: Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J Biol Chem. 274:31648?31654. 1999. View Article : Google Scholar : PubMed/NCBI |
29 | Kang YH and Lee SJ: The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. J Cell Physiol. 217:23?33. 2008. View Article : Google Scholar : PubMed/NCBI |
30 | Yang CY and Meng CL: Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines. J Dent Res. 73:1407?1415. 1994. View Article : Google Scholar : PubMed/NCBI |
31 | Wong DY, Chang KW, Chen CF and Chang RC: Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas-OC1 and OC2. J Oral Maxillofac Surg. 48:385?390. 1990. View Article : Google Scholar : PubMed/NCBI |
32 | Wu WC, Hsiao JR, Lian YY, Lin CY and Huang BM: The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol. 60:103?111. 2007. View Article : Google Scholar : PubMed/NCBI |
33 | Kang FC, Wang SC, So EC, Chang MM, Wong KL, Cheng KS, Chen YC and Huang BM: Propofol may increase caspase and MAPK pathways, and suppress the Akt pathway to induce apoptosis in MA-10 mouse Leydig tumor cells. Oncol Rep. 41:3565?3574. 2019.PubMed/NCBI |
34 | Kang FC, Chen YC, Wang SC, So EC and Huang BM: Propofol induces apoptosis by activating caspases and the MAPK pathways, and inhibiting the Akt pathway in TM3 mouse Leydig stem/progenitor cells. Int J Mol Med. 46:439?448. 2020.PubMed/NCBI |
35 | Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265?275. 1951.PubMed/NCBI |
36 | Chang MM, Lai MS, Hong SY, Pan BS, Huang H, Yang SH, Wu CC, Sun HS, Chuang JI, Wang CY and Huang BM: FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells. Cancer Sci. 109:3503?3518. 2018. View Article : Google Scholar : PubMed/NCBI |
37 | Chang MM, Pan BS, Wang CY and Huang BM: Cordycepin-induced unfolded protein response-dependent cell death, and AKT/MAPK-mediated drug resistance in mouse testicular tumor cells. Cancer Med. 8:3949?3964. 2019. View Article : Google Scholar : PubMed/NCBI |
38 | van Engeland M, Ramaekers FC, Schutte B and Reutelingsperger CP: A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 24:131?139. 1996. View Article : Google Scholar : PubMed/NCBI |
39 | Li W and Chou IN: Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol. 114:132?139. 1992. View Article : Google Scholar : PubMed/NCBI |
40 | Ochi T, Nakajimar F and Fukumori N: Different effects of inorganic and dimethylated arsenic compounds on cell morphology, cytoskeletal organization, and DNA synthesis in cultured Chinese hamster V79 cells. Arch Toxicol. 72:566?573. 1998. View Article : Google Scholar : PubMed/NCBI |
41 | Zuk A, Targosz-Korecka M and Szymonski M: Effect of sel ected drugs used in asthma treatment on morphology and elastic properties of red blood cells. Int J Nanomedicine. 6:249?57. 2011. View Article : Google Scholar : PubMed/NCBI |
42 | Vahter M: Methylation of inorganic arsenic in different mammalian species and population groups. Sci Prog. 82:69?88. 1999. View Article : Google Scholar : PubMed/NCBI |
43 | Lin KW, Behl S, Furst A, Chien P and Toia RF: Formation of dimethylarsinic acid from methylation of sodium arsenite in lumbricus terrestris. Toxicol In Vitro. 12:197?199. 1998. View Article : Google Scholar : PubMed/NCBI |
44 | Hartwell LH and Weinert TA: Checkpoints: Controls that ensure the order of cell cycle events. Science. 246:629?634. 1989. View Article : Google Scholar : PubMed/NCBI |
45 | Yih LH, Wu YC, Hsu NC and Kuo HH: Arsenic trioxide induces abnormal mitotic spindles through a PIP4KIIγ/Rho pathway. Toxicol Sci. 128:115?125. 2012. View Article : Google Scholar : PubMed/NCBI |
46 | Ling YH, Jiang JD, Holland JF and Perez-Soler R: Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 62:529?538. 2002. View Article : Google Scholar : PubMed/NCBI |
47 | Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S and Zeillinger R: Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Int J Oncol. 22:51?57. 2003.PubMed/NCBI |
48 | Shu CH, Yang WK, Shih YL, Kuo ML and Huang TS: Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis. Apoptosis. 2:463?470. 1997. View Article : Google Scholar : PubMed/NCBI |
49 | Tyagi AK, Singh RP, Agarwal C, Chan DC and Agarwal R: Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clin Cancer Res. 8:3512?3519. 2002.PubMed/NCBI |
50 | Brown JM and Attardi LD: The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 5:231?237. 2005. View Article : Google Scholar : PubMed/NCBI |
51 | Fan TJ, Han LH, Cong RS and Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 37:719?727. 2005. View Article : Google Scholar : PubMed/NCBI |
52 | Cheng B, Yang X, Han Z, An L and Liu S: Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA. Auris Nasus Larynx. 35:95?101. 2008. View Article : Google Scholar : PubMed/NCBI |
53 | Jiang XH, Wong BC, Yuen ST, Jiang SH, Cho CH, Lai KC, Lin MC, Kung HF and Lam SK: Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation ofcaspase-3. Int J Cancer. 91:173?179. 2001. View Article : Google Scholar : PubMed/NCBI |
54 | Wu X, Shi J, Wu Y, Tao Y, Hou J, Meng X, Hu X, Han Y, Jiang W, Tang S, et al: Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2. Cancer Biol Ther. 10:1201?1214. 2010. View Article : Google Scholar : PubMed/NCBI |
55 | Binet F, Chiasson S and Girard D: Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophils. Biochem Biophys Res Commun. 391:18?23. 2010. View Article : Google Scholar : PubMed/NCBI |
56 | Lunghi P, Giuliani N, Mazzera L, Lombardi G, Ricca M, Corradi A, Cantoni AM, Salvatore L, Riccioni R, Costanzo A, et al: Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood. 112:2450?2462. 2008. View Article : Google Scholar : PubMed/NCBI |
57 | Kircelli F, Akay C and Gazitt Y: Arsenic trioxide induces p53-dependent apoptotic signals in myeloma cells with SiRNA-silenced p53: MAP kinase pathway is preferentially activated in cells expressing inactivated p53. Int J Oncol. 30:993?1001. 2007.PubMed/NCBI |
58 | Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, Fok TF, Ng PC, Shing MM, Chuen CK and Yuen PM: Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia. Int J Oncol. 27:537?545. 2005.PubMed/NCBI |
59 | Ivanov VN and Hei TK: Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: A role of combined treatment versus monotherapy. Apoptosis. 16:1268?1284. 2011. View Article : Google Scholar : PubMed/NCBI |
60 | Shen L and Zhang G, Lou Z, Xu G and Zhang G: Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. BMC Complement Altern Med. 17:1062017. View Article : Google Scholar : PubMed/NCBI |
61 | Wang X and Zhang M: Synergistic effects of valproic acid and arsenic trioxide on RPMI8226 cells in vitro and the possible underlying mechanisms. Mol Med Rep. 12:1449?1456. 2015. View Article : Google Scholar : PubMed/NCBI |
62 | Amr?n D, S?nchez Y, Fern?ndez C, Ramos AM, de Blas E, Br?ard J, Calle C and Aller P: Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. Biochim Biophys Acta. 1773:1653?1663. 2007. View Article : Google Scholar : PubMed/NCBI |
63 | Alvarado-Kristensson M, Melander F, Leandersson K, R?nnstrand L, Wernstedt C and Andersson T: p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med. 199:449?458. 2004. View Article : Google Scholar : PubMed/NCBI |
64 | Grethe S, Ares MP, Andersson T and P?rn-Ares MI: p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res. 298:632?642. 2004. View Article : Google Scholar : PubMed/NCBI |
65 | Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW and Oh YJ: Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and ?9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem. 279:20451?2060. 2004. View Article : Google Scholar : PubMed/NCBI |
66 | Falchi L, Verstovsek S, Ravandi-Kashani F and Kantarjian HM: The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy. Cancer. 122:1160?1168. 2016. View Article : Google Scholar : PubMed/NCBI |
67 | Torka P, Al Ustwani O, Wetzler M, Wang ES and Griffiths EA: Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia. Blood Rev. 30:201?211. 2016. View Article : Google Scholar : PubMed/NCBI |